Iconovo AB ICO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 1.06
- Day Range
- SEK 1.05–1.09
- 52-Week Range
- SEK 0.87–1.74
- Bid/Ask
- SEK 1.07 / SEK 1.11
- Shares Outstanding
- 96.17M
- Market Cap
- SEK 104.83M
- Volume/Avg
- 9,287 / 61,708
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 40.31
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Iconovo AB develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company provides several types of patent-protected inhalers that can generate commercial opportunities in the development of novel pharmaceuticals and vaccines and at patent expirations for established pharmaceuticals. The project is a generic version of the asthma and COPD product Symbicort.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 12
- Website
- https://www.iconovo.se
Valuation
Metric | ICO |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.74 |
Price/Sales | 40.31 |
Price/Cash Flow | — |
Price/Earnings
ICO
Financial Strength
Metric | ICO |
|---|---|
Quick Ratio | 2.84 |
Current Ratio | 2.84 |
Interest Coverage | −108.88 |
Quick Ratio
ICO
Profitability
Metric | ICO |
|---|---|
Return on Assets (Normalized) | −24.45% |
Return on Equity (Normalized) | −26.67% |
Return on Invested Capital (Normalized) | −25.70% |
Return on Assets
ICO
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|%#Jz@yP> | LOCK|ntb< | $74B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|%>NTbGB! | LOCK|NQMb | $50B | |||
| Haleon PLC ADR HLN | LOCK|<Km>!D | LOCK|vm | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|n%?Y%MX | LOCK|@% | $34B | |||
| Viatris Inc VTRS | LOCK|XwPkL^ | LOCK|msG | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|Y!p | LOCK|PZ | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|n%^p#<@ | LOCK|P> | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|f<^$<&z | LOCK|<P | $5B | |||
| Perrigo Co PLC PRGO | LOCK|m<f$HV% | LOCK|W! | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|WQd^YQ! | LOCK|%qNr$ | $2B |
United States